Deutsche Bank
FOLD

Deutsche Bank’s Amicus Therapeutics FOLD Stock Holding History

Deutsche Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$7K – 5234
2015
Q2 		$7K Buy
+500
New +$6.01K ﹤0.01% 5106

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Deutsche Bank's FOLD Position: Q1 2026 in Review

Deutsche Bank reduced its Amicus Therapeutics (FOLD) stake by 92% in Q1 2026, selling an estimated $45.5M and leaving 282,792 shares worth $4.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

Deutsche Bank first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $127M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Deutsche Bank held 282,792 shares of Amicus Therapeutics worth $4.09M as of Q1 2026.
  • Deutsche Bank sold 3,174,436 Amicus Therapeutics shares in Q1 2026, an estimated $45.5M.
  • Amicus Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1402 holding.
  • Deutsche Bank first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Amicus Therapeutics position peaked at $127M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.